A comparison of the effects of Sevoflurane and Isoflurane on cardiovascular parameters measured by cardiac magnetic resonance imaging in paediatric patients with congenital heart disease. A randomised controlled trial.

ISRCTN ISRCTN81324728
DOI https://doi.org/10.1186/ISRCTN81324728
Secondary identifying numbers N0013145919
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
15/07/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Priti Dalal
Scientific

Theatres
2nd Floor, New Guy House
Guy's Hospital
St Thomas' Street
London
SE1 9RT
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeOther
Scientific title
Study objectivesSevoflurane and isoflurane are commonly used to anaesthetise patients with congenital heart disease. Which agent causes the least depression of cardiac function?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedHeart disease
InterventionThe routine study usually lasts 1 hour. For the first 30 minutes, each subject will be anaesthetised with one of the agents. The agent will then be swapped and the patients anaesthetised with the other agent for the remaining 30 minutes. Variables will be recorded at the end of each period.
Intervention typeOther
Primary outcome measureCardiac output, aortic and pulmonary blood flow, arterial pressure, systemic vascular resistance.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/09/2003
Completion date01/09/2004

Eligibility

Participant type(s)Patient
Age groupChild
SexBoth
Target number of participants10
Key inclusion criteriaSubjects will be children with congenital cardiac abnormalities who are undergoing magnetic resonance imaging to achieve an accurate diagnosis and determine future treatment options.
Key exclusion criteria1. Patient or parental refusal
2. Allergic, anaphylactic or other reactions to inhalational anaesthetic agents
3. Patients older than 16 years of age.
Date of first enrolment01/09/2003
Date of final enrolment01/09/2004

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Theatres
London
SE1 9RT
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Hospital/treatment centre

Guy's and St. Thomas' NHS Foundation Trust (UK) Own account, NHS R&D Support Funding

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/02/2008 Yes No